Hepion Pharmaceuticals, Inc. announced that it will receive $5,000,004 in funding on September 28, 2023. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | +6.11% | -8.55% | -57.10% |
04-22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
04-22 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.10% | 7.17M | |
+2.90% | 108B | |
+10.02% | 105B | |
+1.57% | 23.46B | |
-11.82% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-7.53% | 17.19B | |
+6.25% | 13.99B | |
+35.51% | 12.53B |
- Stock Market
- Equities
- HEPA Stock
- News Hepion Pharmaceuticals, Inc.
- Hepion Pharmaceuticals, Inc. announced that it expects to receive $5.000004 million in funding